Shares of GSK PLC GSK rose 1.40% to £14.80 Monday, on what proved to be an all-around favorable trading session for the stock ...
The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of ...
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...
Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine.
Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...
AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes ...
Test results are pending on a worker who had contact with infected herds, California officials report. Meanwhile, federal scientists are studying H5N1 genes in dairy workers in search of mutations ...
GST applicants from Kerala, Nagaland, and Telangana must follow new Aadhaar-based biometric authentication and document ...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often ...
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback